Hang Seng Index
WuXi AppTec
A global CRO/CDMO providing chemistry, drug discovery, and development services to pharmaceutical companies worldwide. Hang Seng Index constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
2359.HK Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'21-27.8%'22-8%'23-46%'24+5.1%'25+104.4%YTD+41.3%
Money in ▸·
WuXi AppTecapprox. CN¥40.3B
▸ Money out·
Financials & Segments
- Total revenue · approx. CN¥40.3B (FY2023)
- Segments · WuXi Chemistry · Testing · Biologics & cell/gene therapy
Revenue from
No refined links yet.
Pays to
No refined links yet.